Cytek Biosciences Inc (CTKB)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 200,453 | 193,015 | 164,036 | 127,950 | 92,839 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $200,453K ÷ $—K
= —
The data provided indicates that the receivables turnover for Cytek Biosciences Inc is not available for the years ending December 31, 2020 to December 31, 2024. Without this specific ratio, it is challenging to assess how efficiently the company is collecting its accounts receivable during these years.
Receivables turnover is a significant financial ratio that helps in evaluating a company's effectiveness in credit management and collection of outstanding payments from its customers. A high receivables turnover ratio typically indicates that the company is efficiently collecting payments from its customers, while a low ratio may suggest issues with collections or credit policies.
In the absence of the receivables turnover data for Cytek Biosciences Inc, it is recommended to further investigate the company's accounts receivable management practices and policies to understand how effectively it is managing its receivables during the mentioned period. This analysis will provide insights into the company's financial health and its ability to convert credit sales into cash.
Peer comparison
Dec 31, 2024